爱体育平台(中国)酒曲有限公司(akrevia.com)创办于2001年1月,注册资金6.80 亿元,集团净资产达14.80 亿元,是一家专业生产山东梁山大曲,芝麻香型专用曲的梁山大曲厂家,并提供有关于山东酒曲价格和梁山大曲价格等信息,质量优越,服务上乘。
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Total raised: $30M
Founded date: 2015
Funding Rounds 1
Date | Series | Amount | Investors |
27.09.2018 | Series A | $30M | F-Prime Ca... |
Mentions in press and media 9
Date | Title | Description | Source |
03.03.2020 | Akrevia Therapeutics Rebrands as Xilio Therapeutics and Anno... | - | solasta-ve... |
28.09.2018 | Term Sheet — Friday, September 28 | THREE THINGS Good morning, Term Sheet readers. Paid Content Securing the enterprise without bounda... | fortune.co... |
28.09.2018 | Biotech Startup Akrevia Therapeutics Lands $30M to Develop N... | Akrevia Therapeutic, a Cambridge, MA-based biotech startup focused on developing highly-potent, tumo... | hitconsult... |
27.09.2018 | Akrevia Therapeutics Raises $30M in Series A Financing | Akrevia Therapeutics, a Cambridge, Mass.-based biopharmaceutical company focused on developing tumor... | finsmes.co... |
27.09.2018 | Akrevia Therapeutics Launches with $30M Series A Financing L... | - | fprimecapi... |
27.09.2018 | Akrevia launches with $30M in Series A financing | The company’s development platform, Aklusion, is designed to allow antibodies, cytokines and chemoki... | medcitynew... |
27.09.2018 | Akrevia Therapeutics Scores $30M | CAMBRIDGE, MA, Akrevia Therapeutics today announced the closing of a $30 million Series A financin... | vcnewsdail... |
27.09.2018 | Akrevia Therapeutics Launches with $30M Series A Financing L... | Akrevia Therapeutics, a privately-held biopharmaceutical company focused on developing highly-potent... | citybizlis... |
- | Akrevia launches with $30M in Series A financing | A company developing a preclinical immunotherapy drug has launched with a two industry veterans at t... | medcitynew... |